Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies.

Tabellini G, Patrizi O, Dobbs K, Lougaris V, Baronio M, Coltrini D, Plebani A, Badolato R, Notarangelo LD, Parolini S.

Front Immunol. 2019 Jul 24;10:1757. doi: 10.3389/fimmu.2019.01757. eCollection 2019. Review.

2.

Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer.

Ronca R, Tamma R, Coltrini D, Ruggieri S, Presta M, Ribatti D.

Oncotarget. 2017 Aug 1;8(47):82583-82592. doi: 10.18632/oncotarget.19773. eCollection 2017 Oct 10.

3.

Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.

Rezzola S, Corsini M, Chiodelli P, Cancarini A, Nawaz IM, Coltrini D, Mitola S, Ronca R, Belleri M, Lista L, Rusciano D, De Rosa M, Pavone V, Semeraro F, Presta M.

Diabetologia. 2017 Apr;60(4):719-728. doi: 10.1007/s00125-016-4204-0. Epub 2017 Jan 13.

PMID:
28083635
4.

Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease.

Giacomini A, Ackermann M, Belleri M, Coltrini D, Nico B, Ribatti D, Konerding MA, Presta M, Righi M.

Angiogenesis. 2015 Oct;18(4):499-510. doi: 10.1007/s10456-015-9481-6. Epub 2015 Aug 27.

PMID:
26310512
5.

β3 Integrin Promotes Long-Lasting Activation and Polarization of Vascular Endothelial Growth Factor Receptor 2 by Immobilized Ligand.

Ravelli C, Grillo E, Corsini M, Coltrini D, Presta M, Mitola S.

Arterioscler Thromb Vasc Biol. 2015 Oct;35(10):2161-71. doi: 10.1161/ATVBAHA.115.306230. Epub 2015 Aug 20.

6.

Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy.

Ronca R, Giacomini A, Di Salle E, Coltrini D, Pagano K, Ragona L, Matarazzo S, Rezzola S, Maiolo D, Torrella R, Moroni E, Mazzieri R, Escobar G, Mor M, Colombo G, Presta M.

Cancer Cell. 2015 Aug 10;28(2):225-39. doi: 10.1016/j.ccell.2015.07.002.

7.

B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape.

Pesce S, Tabellini G, Cantoni C, Patrizi O, Coltrini D, Rampinelli F, Matta J, Vivier E, Moretta A, Parolini S, Marcenaro E.

Oncoimmunology. 2015 Jan 22;4(4):e1001224. eCollection 2015 Apr.

8.

Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis.

Tabellini G, Benassi M, Marcenaro E, Coltrini D, Patrizi O, Ricotta D, Rampinelli F, Moretta A, Parolini S.

Case Rep Oncol. 2014 Jan 24;7(1):70-8. doi: 10.1159/000357802. eCollection 2014 Jan.

9.

Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.

Ronca R, Di Salle E, Giacomini A, Leali D, Alessi P, Coltrini D, Ravelli C, Matarazzo S, Ribatti D, Vermi W, Presta M.

Mol Cancer Ther. 2013 Dec;12(12):2760-71. doi: 10.1158/1535-7163.MCT-13-0487. Epub 2013 Oct 15.

10.

Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.

Belleri M, Ronca R, Coltrini D, Nico B, Ribatti D, Poliani PL, Giacomini A, Alessi P, Marchesini S, Santos MB, Bongarzone ER, Presta M.

Brain. 2013 Sep;136(Pt 9):2859-75. doi: 10.1093/brain/awt215.

11.

Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.

Ronca R, Alessi P, Coltrini D, Di Salle E, Giacomini A, Leali D, Corsini M, Belleri M, Tobia C, Garlanda C, Bonomi E, Tardanico R, Vermi W, Presta M.

J Pathol. 2013 Jun;230(2):228-38. doi: 10.1002/path.4181.

PMID:
23424081
12.

Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR.

Coltrini D, Di Salle E, Ronca R, Belleri M, Testini C, Presta M.

Angiogenesis. 2013 Apr;16(2):469-77. doi: 10.1007/s10456-012-9324-7. Epub 2012 Nov 11.

PMID:
23143707
13.

Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis.

Leali D, Inforzato A, Ronca R, Bianchi R, Belleri M, Coltrini D, Di Salle E, Sironi M, Norata GD, Bottazzi B, Garlanda C, Day AJ, Presta M.

Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):696-703. doi: 10.1161/ATVBAHA.111.243998. Epub 2012 Jan 19.

14.

Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors.

Leali D, Alessi P, Coltrini D, Ronca R, Corsini M, Nardo G, Indraccolo S, Presta M.

Mol Cancer Ther. 2011 Sep;10(9):1600-10. doi: 10.1158/1535-7163.MCT-11-0286. Epub 2011 Jul 15.

15.

Antiangiogenic activity of a neutralizing human single-chain antibody fragment against fibroblast growth factor receptor 1.

Ronca R, Benzoni P, Leali D, Urbinati C, Belleri M, Corsini M, Alessi P, Coltrini D, Calza S, Presta M, Dell'Era P.

Mol Cancer Ther. 2010 Dec;9(12):3244-53. doi: 10.1158/1535-7163.MCT-10-0417. Epub 2010 Oct 12.

16.

Fibroblast growth factor-2 antagonist and antiangiogenic activity of long-pentraxin 3-derived synthetic peptides.

Leali D, Alessi P, Coltrini D, Rusnati M, Zetta L, Presta M.

Curr Pharm Des. 2009;15(30):3577-89. Review.

PMID:
19860702
17.

Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice.

Coltrini D, Ronca R, Belleri M, Zardi L, Indraccolo S, Scarlato V, Giavazzi R, Presta M.

J Pathol. 2009 Dec;219(4):455-62. doi: 10.1002/path.2626.

PMID:
19824060
18.

alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers.

Belleri M, Ribatti D, Savio M, Stivala LA, Forti L, Tanghetti E, Alessi P, Coltrini D, Bugatti A, Mitola S, Nicoli S, Vannini V, Presta M.

Mol Cancer Ther. 2008 Dec;7(12):3761-70. doi: 10.1158/1535-7163.MCT-07-2351.

19.

A pro-inflammatory signature mediates FGF2-induced angiogenesis.

Andrés G, Leali D, Mitola S, Coltrini D, Camozzi M, Corsini M, Belleri M, Hirsch E, Schwendener RA, Christofori G, Alcamí A, Presta M.

J Cell Mol Med. 2009 Aug;13(8B):2083-108. doi: 10.1111/j.1582-4934.2008.00415.x.

20.

Cardiac microvascular endothelial cells express a functional Ca+ -sensing receptor.

Berra Romani R, Raqeeb A, Laforenza U, Scaffino MF, Moccia F, Avelino-Cruz JE, Oldani A, Coltrini D, Milesi V, Taglietti V, Tanzi F.

J Vasc Res. 2009;46(1):73-82. doi: 10.1159/000140677. Epub 2008 Jun 24.

21.

Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.

Stabile H, Mitola S, Moroni E, Belleri M, Nicoli S, Coltrini D, Peri F, Pessi A, Orsatti L, Talamo F, Castronovo V, Waltregny D, Cotelli F, Ribatti D, Presta M.

Blood. 2007 Mar 1;109(5):1834-40. Epub 2006 Oct 31.

22.

Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine.

Mitola S, Belleri M, Urbinati C, Coltrini D, Sparatore B, Pedrazzi M, Melloni E, Presta M.

J Immunol. 2006 Jan 1;176(1):12-5.

23.

Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo.

Camozzi M, Zacchigna S, Rusnati M, Coltrini D, Ramirez-Correa G, Bottazzi B, Mantovani A, Giacca M, Presta M.

Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1837-42. Epub 2005 Jul 14.

PMID:
16020751
24.

Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.

Giavazzi R, Sennino B, Coltrini D, Garofalo A, Dossi R, Ronca R, Tosatti MP, Presta M.

Am J Pathol. 2003 Jun;162(6):1913-26.

25.

Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives.

Leali D, Belleri M, Urbinati C, Coltrini D, Oreste P, Zoppetti G, Ribatti D, Rusnati M, Presta M.

J Biol Chem. 2001 Oct 12;276(41):37900-8. Epub 2001 Jul 25.

26.

P2y1 and P2y2 receptor-operated Ca2+ signals in primary cultures of cardiac microvascular endothelial cells.

Moccia F, Baruffi S, Spaggiari S, Coltrini D, Berra-Romani R, Signorelli S, Castelli L, Taglietti V, Tanzi F.

Microvasc Res. 2001 May;61(3):240-52.

PMID:
11336535
27.

Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors.

Giavazzi R, Giuliani R, Coltrini D, Bani MR, Ferri C, Sennino B, Tosatti MP, Stoppacciaro A, Presta M.

Cancer Res. 2001 Jan 1;61(1):309-17.

29.

Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study.

Konerding MA, Fait E, Dimitropoulou C, Malkusch W, Ferri C, Giavazzi R, Coltrini D, Presta M.

Am J Pathol. 1998 Jun;152(6):1607-16.

30.

Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic mice.

Rusnati M, Coltrini D, Campioni D, Tanghetti E, Corallini A, Barbanti-Brodano G, Giuliani R, Gibellini D, Presta M.

AIDS. 1997 May;11(6):727-36.

PMID:
9143604
31.

Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size.

Rusnati M, Coltrini D, Oreste P, Zoppetti G, Albini A, Noonan D, d'Adda di Fagagna F, Giacca M, Presta M.

J Biol Chem. 1997 Apr 25;272(17):11313-20.

32.

Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient mice.

Sola F, Gualandris A, Belleri M, Giuliani R, Coltrini D, Bastaki M, Tosatti MP, Bonardi F, Vecchi A, Fioretti F, Ciomei M, Grandi M, Mantovani A, Presta M.

Angiogenesis. 1997;1(1):102-116.

PMID:
14517397
33.

Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action.

Coltrini D, Gualandris A, Nelli EE, Parolini S, Molinari-Tosatti MP, Quarto N, Ziche M, Giavazzi R, Presta M.

Cancer Res. 1995 Oct 15;55(20):4729-38.

34.

Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor.

Coltrini D, Rusnati M, Zoppetti G, Oreste P, Grazioli G, Naggi A, Presta M.

Biochem J. 1994 Oct 15;303 ( Pt 2):583-90.

35.

Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.

Rusnati M, Coltrini D, Caccia P, Dell'Era P, Zoppetti G, Oreste P, Valsasina B, Presta M.

Biochem Biophys Res Commun. 1994 Aug 30;203(1):450-8.

PMID:
8074689
36.

Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies.

Coltrini D, Rusnati M, Zoppetti G, Oreste P, Isacchi A, Caccia P, Bergonzoni L, Presta M.

Eur J Biochem. 1993 May 15;214(1):51-8.

37.
38.

Subcellular localization and biological activity of M(r) 18,000 basic fibroblast growth factor: site-directed mutagenesis of a putative nuclear translocation sequence.

Presta M, Gualandris A, Urbinati C, Rusnati M, Coltrini D, Isacchi A, Caccia P, Bergonzoni L.

Growth Factors. 1993;9(4):269-78.

PMID:
8148156

Supplemental Content

Loading ...
Support Center